Brian Kirby

Charles Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland and School of Health Sciences and Charles Institute, University College Dublin, Dublin, Ireland., Ireland

Abbvie (Consultant/Advisory Board)Almirall (Consultant/Advisory Board)Amgen (Consultant/Advisory Board, Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support)Astra Zeneca (Consultant/Advisory Board)Bristol Myers Squibb (Consultant/Advisory Board)Celgene (Consultant/Advisory Board)Eli Lilly (Consultant/Advisory Board)Janssen (Consultant/Advisory Board)Leo (Consultant/Advisory Board)Merck (Consultant/Advisory Board)Moonlake (Consultant/Advisory Board)Novartis (Consultant/Advisory Board)Sanofi (Consultant/Advisory Board)UCB (Consultant/Advisory Board)

Presentation(s):

• Effect Modification of Biologic Survival by Patient Characteristics: A Step Towards Precision Medicine in the Treatment of Psoriasis

  Saturday, August 27, 2022
  1:35 PM – 1:40 PM CEST